USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1

Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer. TNBC does not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2. Cytotoxic chemotherapy and surgery are the current therapeutic strategies for TNBC patients, but the chemore...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yueh-Te, Lin, Joseph, Liu, Yi-En, Chen, Yun-Cen, Liu, Shiang-Ting, Hsu, Kai-Wen, Chen, Dar-Ren, Wu, Han-Tsang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600340/
https://www.ncbi.nlm.nih.gov/pubmed/36291159
http://dx.doi.org/10.3390/cells11203294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600340/
https://www.ncbi.nlm.nih.gov/pubmed/36291159
http://dx.doi.org/10.3390/cells11203294

Ejemplares similares